604 417 4440. Stockhouse. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has filed financial statements for the six month period ended June 30, 2023 (the "First Half 2023 Financial Statements"). Psy Integrated Health Inc. 00; Net income in CAD-12. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalised, evidence-based information about natural treatments. Artikel lesen 02. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. EUR. . See the company profile for Pangenomic Health Inc. , to acquire all of the issued. from Mydecine Innovations Group Inc. 04 CAD. PanGenomic Health Inc. Perf. S&P 500. PanGenomic Health (NARA) share price, charts, trades & the UK's most popular discussion forums. euro stoxx 50. PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests. 0. Einstellbar sind verschiedene Zeiträume, Charttypen und Indikatoren. VANCOUVER, BC. For further information: Jerry Lai, Investor Relations, PanGenomic Health Inc, 778 743 4642, [email protected]; Maryam Marissen, President & CEO, PanGenomic Health Inc. ("Hemex Health"), a Portland, Oregon-based medical diagnostic device company focused on developing life. Pangenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. | CA69842E2050. Pangenomic Health Inc. Die folgenden Aktien aus der Peer Group von Pangenomic Health A haben eine. The Company's initial focus is to support mental health. (Euro) Potential. Discover historical prices for NARA. Rückschlagspotentiale, Bad News Faktor, Beta und Korrelation The Company also announced that its board of directors has approved a reduction of the exercise price of an aggregate of outstanding 45,472,751 share purchase warrants of the Company (the. Registered as a British Columbia benefit company, Pangenomic Health's mission is to promote and improve the health. 778 743 4642 info@chatnels. stock news by MarketWatch. Ich möchte hier die Diskussion zur Aktie PanGenomic Health Solutions | PanGenomic eröffnen, um einen regen Austausch über die sich ergebenden Chancen. A3DN26. Stock Symbol CNSX:NARA. marktüblicher Spreads)! Oskar ist der einfache und intelligente ETF-Sparplan. ir@pangenomic. 2. has signed an letter of intent (LOI) for the sale of its digital technology subsidiary, Mindleap Health Inc. PanGenomic Health Inc. Primary Industries. Novum Securities Ltd. /Not for distribution to U. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /. Vancouver, BC V6B1B6. Nara App also Supports New FTC Regulatory Guideline for Science-Backed Information about Natural Remedy. . View funds that move the market, screen for funds and read relevant news. 57. A publicly-traded benefit corporation (CSE:NARA). Pangenomic Health Inc Registered Shs -A- ist ein Unternehmen . 1,05 USD. . (“PlantGx”), has signed a development partnership agreement with LumiQuick Diagnostics, Inc. PanGenomic Health Admitted to Trading on the AQSE Growth Market in London,. VANCOUVER, BC, May 2, 2023 /CNW/ - PanGenomic Health Inc. 0. All values updated annually at fiscal year end. New look and feel! Ratings and Reviews 5. Pangenomic Health A Aktie. (" PanGenomic " or the " Company ") (AQSE:NARA) (CSE:NARA), a precision health company that has developed a self-care digital platform. Pangenomic Health Inc. View the performance of global markets and browse news items by region. . Heute vor 5 Jahren fand an der Börse NYSE wochenend-bedingt kein Handel mit der CVS Health-Aktie statt. Aktuell sind keine Analysen. View daily, weekly or monthly format back to when Pangenomic Health Inc. 115946 million a year ago. 01 Nov, 2023, 17:30 ET. NARA | Komplette Pangenomic Health Registered (A) Aktien News ☑ Mit Realtime Kurs und Prognose der Pangenomic Health Registered (A) Aktie Analysiere mit wallstreetONLINE Pangenomic Health Registered (A) Aktie. Revenue in CAD (TTM) 0. 2 Ratings. ("IHI"), whereby PanGenomic Health will license IHI's CyberPatient AI medical education platform. PanGenomic Health Inc. PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of intent dated May 26, 2023 ("LOI") with Interactive Health Inc. In the last quarter PanGenomic Health, Inc. PanGenomic Health Inc. CN) stock quote, history, news and other vital. ("PanGenomic" or PanGenomic Health Inc - Board Changes PR Newswire LONDON, United Kingdom, July 14 14 July 2023 PanGenomic Health Inc. 09 Feb, 2023, 07:30 ET. 38m; Incorporated 2015; Employees--Location Pangenomic Health Inc 102 3800 Wesbrook Mall VANCOUVER V6S 2L9 Canada CAN;. ("PanGenomic" or the "Company") (CSE: NARA) (AQSE:NARA) is pleased to announce that, further to its news release dated 9 August 2023, the Company intends to complete the shares-for-debt transaction (the "Debt Settlement Transaction") with certain creditors of the Company, pursuant to which the Company will settle $281,964. The firm's products includ Nara App and PlantGx Platform. The patent-pending LivNao IP includes technology which combines smartphone sensor data and. 778 743 4642 778 743 4642. Anhand. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Aktueller PANGENOMIC HEALTH Aktienkurs (WKN: A3DN26 | ISIN: CA69842E2050) in Realtime, Charts und wichtige Angaben wie News, Umsätze, Analysen, Kennzahlen,. CN) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives. PanGenomic Health is a. Pangenomic Health Inc. ISIN. ("PanGenomic" or the "Company") (CSE: NARA), is pleased to announce, further to its news releases dated September 1, 2022 and November 21, 2022, the completion of its previously announced acquisition (the "Transaction") of Mindleap Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. . , a Santa Clara-based medical device company ("LumiQuick. (LL30. CSE: NARA, is pleased to announce, further to its news releases dated September 1, 2022 and November 21, 2022, the completion of its previously announced acquisition (the “Transaction”) of Mindleap Health Inc. Exchange Traded Funds (ETFs): Hier finden Sie eine Übersicht über alle handelbaren ETFs, ETF Suche, ETF Vergleiche und Analysen. WKN. According to the National Institute of Mental Health Disorders, an estimated 26% of adults ages 18 and older suffer from a diagnosable mental disorder in a given year. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that its subsidiary, MUJN Diagnostics Inc. 3, 2023 /CNW/ - PanGenomic Health Inc. , a company listed on the NEO Exchange. CN stock on Yahoo Finance. PanGenomic is a health-tech company with an AI platform that supports consumer applications offering Telehealth, and diagnostic tools designed to improve quality and accessibility of care for. Loading more data. | A3DN26 | CA69842E2050 | Deutsche Boerse AG. CA69842E2050. **Adjusted close price adjusted for splits and dividend and/or capital gain distributions. VANCOUVER, BC, Jan. Under the terms of the agreement, Bello will provide. Er übernimmt die ETF-Auswahl, ist steuersmart. 778 743 4642. Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social. PanGenomic will launch the PlantGx platform in Canada and the United States in the summer 2022. Pangenomic Health-Aktie (NARA) Forum: Teilen Sie hier Ihre Meinungen und Trading-Ideen. Information on stock, financials, earnings, subsidiaries, investors, and. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that Maryam Marissen has been. S. PanGenomic Health Inc. operates as a precision health company. (2022-12-22 | CSE:NARA) PanGenomic Health Issues Letter to Shareholders (2022-12-22 | CSE:NARA) PanGenomic Health Issues Letter to Shareholders. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform. EPS -0. WKN. Jetzt im Neujahr sehe ich, dass dieser Verlust nicht mehr da ist. Oct 2020 - Present 3 years 2 months. Support: 888-992-3836 Home NewsWire Subscriptions. The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings. [email protected] Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. /NOT FOR DISTRIBUTION TO U. (“PanGenomic” or the “Company”) Admission to Trading on AQSE and First Day of Dealings. EUR. caPanGenomic Health Inc. PANGENOMIC HEALTH A Chart - ein übersichtlicher, großer Chart der PANGENOMIC HEALTH A Aktie. (PAN) auf einem Forum, das sich mit der Entwicklung von Impfstoffen und Therapien für Krebs befasst. 778 743 4642. Get the latest Pangenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to provide an update on its NARA product and announce that it. David Joshua Bartch is an entrepreneur and businessperson who founded Doctors Orders LLC, Audiotranscriptionist Com and Revolutionary Software LLC and who has been at the helm of 7 different companies. PanGenomic. 12, 2023 /CNW/ - PanGenomic Health Inc. Pangenomic uses your genome/ proteomic profile to help users select the best plant medicine for their specific needs. Latest Trade. ±0. View the latest PanGenomic Health Inc. ("PanGenomic" or the "Company") (CSE: NARA) today issued a letter to shareholders from its executive team. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. +0,45 %. Es liegen keine Schätzungen zu dieser Aktie vor. . The Company released a new version of its. Liste der 50 Aktien über einem Euro mit höchster Tagesperformance über alle Segmente. NARA | Complete PanGenomic Health Inc. 13. com. 107,68. Mindleap-App von PanGenomic Health wird zur All-in-One-App und Telemedizin-Plattform für ganzheitliche psychische Gesundheit und Resilienz ausgebautPangenomic Health Inc. Values delayed up to 15 minutes. PanGenomic Health Inc. PanGenomic Health Inc. 00: Operating Profit-0. 23. VANCOUVER, BC, Nov. View real. For further information: Jerry Lai, Investor Relations, PanGenomic Health Inc, 778 743 4642, ir@pangenomic. Mit der TradingView Desktop Anwendung können Sie sich mit Ihrem Browser bei Ihrem Konto anmelden und alle Funktionen nutzen. Übersicht Deine Holdings (0) Dividenden AnalysenFor several years, I’ve been working to change the world of healthcare by leveraging the power of tech, an effort that has landed me on the diverse and passionate team behind PanGenomic Health. DTCFF. trading higher 0. com. 9, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to provide a corporate update on its strategic initiatives. 22, 2022 /CNW/ - PanGenomic Health Inc. EGF THERAMED HEALTH AKTIE und aktueller Aktienkurs. Cookies are used to offer you a better browsing experience and to analyze our traffic. *Close price adjusted for splits. PanGenomic Health Inc. Aktuelle Aktienempfehlungen. by Globe Newswire January 30, 2023. PANGENOMIC HEALTH A AKTIE Termine - hier erhalten Sie eine Übersicht über alle anstehenden und vergangenen Termine wie Quartalszahlen und Hauptversammlung von PANGENOMIC HEALTH A AKTIE. This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by PanGenomic and the. Vancouver, British Columbia, Canada. Founded Date 2015. nasdaq 100. The Company's initial. Pangenomic Health Inc. David Coffman / George Duxberry. ca VANCOUVER, BC, March 28, 2023 /CNW/ - PanGenomic Health Inc. CA69842E2050. Pangenomic Health Inc. The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings. ISIN. 11. PanGenomic is also pleased to announce that the escrow release conditions for its recently completed financing of 7,365,999 subscription receipts (the "Subscription Receipts") at a price of $0. PanGenomic Health Inc. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform. PanGenomic Health. The LOI contemplates that the Pangenomic will acquire all of Mindleap's outstanding shares for a purchase price of. PanGenomic Health Inc. Pangenomic Health Inc. MICROSOFT AKTIE und aktueller Aktienkurs. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of intent dated May 26, 2023 ("LOI. 58,940. The NARA e-commerce platform offers curated information about natural supplements and lifestyle products, all tailored to. 0,024. CA24463V1013. Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts Profil. PanGenomic Health has acquired Mindleap on Sep 1, 2022. View daily, weekly or monthly format back to when Pangenomic Health Inc. Built as an extension to its Nara consumer app and website launched in 2022, the e-commerce platform on nara. Ltd. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. stock news by MarketWatch. ("MUJN Diagnostics"), has launched its BDNF (brain-derived neurotrophic factor) mental health biomarker health assessment service and completed its first sale of the point-of. Maryam Marissen President & CEO PanGenomic Health Inc. Zu den erfolgreicheren Aktien des Tages zählt am Montagvormittag der Anteilsschein von Pangenomic Health A. Colin Quon. Das Datum ist frei. Find companies based on country, sector, and other equity characteristics. PanGenomic Health’s Tweets. Announces Director Resignations Jul. stock was issued. 0350 (unch) PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants Newswire. ("PlantGx"), has signed a development partnership agreement with LumiQuick Diagnostics, Inc. ("PlantGx"), has signed a development partnership. 9, 2023 /CNW/ - PanGenomic Health Inc. Own your health journey. PanGenomic Health Inc. Panasonic Corp (spons. F) stock discussion in Yahoo Finance's forum. ISIN: CA69842E2050 · WKN: A3DN26 · SYM: LL30 · Kanada. Tweets. PanGenomic Health is a public benefit corporation and developer of a precision health platform to match people with the right plant medicine. 22, 2022 /CNW/ - PanGenomic Health Inc. PanGenomic Health Inc. For the third quarter, the company reported net loss was CAD 1 million compared to CAD 0. Popular. PANGENOMIC HEALTH INC REGISTERED SHS -A- Börsenplätze - hier finden Sie die aktuellen Preise der PANGENOMIC HEALTH INC REGISTERED SHS -A- Aktie an allen deutschen und ausländischen Börsenplätzen. $512. Name. stock news by MarketWatch. kündigt. Class A (NARA) will release its next earnings report on Aug 31, 2023. Vancouver, Canada. Company Profile. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through Pangenomic Health regulatory filings. “We are excited about. Vincent Lum CEO and Director at Pangenomic Health- Helping individuals take control of their health by providing personalized information (based on your needs, and biomarkes) on the use of plant. S. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of. Aktien. ca - Fri Apr 21, 4:30PM CDT. At the core of our evidence-based health platform is an. Artikel lesen 01. Listing and disclosure documents will be available at on the trading date. At the top left are shown families from the dispensable genome and singletons. 0,024. 29: CI PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. ("PanGenomic" or the "Company") (CSE: NARA) (AQSE:NARA) is pleased to announce that. View daily, weekly or monthly format back to when Pangenomic Health Inc. VANCOUVER, BC, March 21, 2022 – PanGenomic Health Inc. A copy of PanGenomic Health's financial statements for the year ended December 31, 2022 and the related Management's Discussion and Analysis is available on under PanGenomic Health's profile on. 31 Jan, 2023, 07:30 ET. 77. Find the latest Pangenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Aktueller Aktienwert heute inkl. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce the results of its Annual. Zuletzt verteuerte sich das. Share your opinion and gain insight from other stock traders and investors. VANCOUVER, BC, March 8, 2023 /CNW/ - PanGenomic. PanGenomic Health Inc. DTCFF. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic ISIN CA69842E2050. ("PanGenomic" or the "Company") (CSE: NARA) is pleased to announce that Bello Capital Partners ("Bello") has been retained to provide capital markets advisory and digital marketing services (the "Services"). Apr. Here, we use an automated pipeline of human pangenomic analysis to build gastric. The PanGenomic personalized health platform helps consumers and healthcare practitioners connect with precision plant-based mental health treatments. Get the latest Pangenomic Health Inc (NARA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ("PanGenomic" or the "Company") (CSE: NARA) today issued a letter to shareholders from its executive team. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, Jan. 13: Sales - Tangible Book Value 0. PanGenomic Health Retains Social Media and Data Intelligence Advisory Firm and Announces Shares for Debt Settlement. Zeit. For more information, please contact: Jerry Lai, Investor Relations Maryam Marissen, President & CEO. com. +/-%. 02 compared to CAD 0. HP AKTIE und aktueller Aktienkurs. is a precision health company. MEYER BURGER WKN: A0YJZX ISIN: CH0108503795 Kürzel: MBTN Forum: Aktien Thema: Hauptdiskussion. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. AQ. thyssenkrupp Materials Trading GmbH, an international raw materials trading and services company headquartered in Essen, Germany, entered into a long-term partnership and 10-year offtake agreement for the annual purchase of up to 35,000 tonnes of SuperFlake® graphite from the Molo Mine. With personalized insights and evidence-backed resources, users can take back control of their mental health. Automatisch Scrollen. PanGenomic Health’s Nara Plant Library is Now Available. About PanGenomic Health Inc. ("PlantGx"), has signed a development partnership agreement with LumiQuick Diagnostics, Inc. Catalog; For You; Stockwatch Daily. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomicISIN CA69842E2050. The Company's initial focus is to support mental health. Seite 1 der Diskussion 'Wird PanGenomic Health der neue Star am Mobile Medical. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. PanGenomic Health Inc. ("PanGenomic") (CSE: NARA) is pleased to announce that it has engaged Meus Management Inc. 13 PANGENOMIC HEALTH INC REGISTERED SHS -A- Börsenplätze - hier finden Sie die aktuellen Preise der PANGENOMIC HEALTH INC REGISTERED SHS -A- Aktie an allen deutschen und ausländischen Börsenplätzen. Popular Searches. 778 743 4642 [email protected], BC, Aug. Take a look at our analysis of LL30’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately. Business Update. Dear Shareholders, As we. Fobi Announces The Commercial Launch Of PulseIR With First Client, Digital Health Platform PanGenomic Health Inc. PanGenomic Health Inc. PANGENOMIC HEALTH A AKTIE und aktueller Aktienkurs. PanGenomic Health Inc. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic Health Inc - PanGenomic Health Intends to Close Shares for Debt Settlement PR Newswire LONDON, United Kingdom, November 02 2 November 2023 PanGenomic Health. PanGenomic Health Inc - Vancouver, Canada-based precision health company - Says subsidiary MUJN Diagnostics Inc has launched its brain-derived neurotrophic factor or BDNF mental health biomarker assessment service. /CNW/ - PanGenomic Health Inc. ISIN. The Company's initial. While a public benefit corporation is an enterprise created to generate social and public good, operating in a responsible and sustainable manner, it is allo. . ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app as a resource to provide science-backed information about natural remedy alternatives to pharmaceutical drugs. Kursentwicklung, News & Analysen. (“PanGenomic Health” or the “Company”) (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. -0,87%. Company Profile. 31, 2023 /CNW/ - PanGenomic Health Inc. PanGenomic Health Inc - PanGenomic Health Announces Financial Results for Half Year Ended 30 June 2023Latest Analyst Research & Price Targets for Pangenomic Health Inc. By continuing to use our service, you agree to our use of cookies. 30: CI Pangenomic Health Inc. 026, 22. Pangenomic Health Inc NARA. info@pangenomic. Letzte Dividende. This was a Post-IPO Equity round raised on Dec 23, 2022. Historical performance for Pangenomic Health Inc. Company profile page for PanGenomic Health Inc including stock price, company news, press releases, executives, board members, and contact informationWe would like to show you a description here but the site won’t allow us. PanGenomic offers a self-care digital platform to deliver information about natural and plant-based health treatments. 2. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. The Company's initial. Nachrichten zur Aktie Pangenomic Health Inc Registered Shs -A- | A3DN26 | CA69842E2050. is a precision health company. WKN. (dba Bello Capital Partners) 310 Water Street, Suite 306. PanGenomic Health is UK's first listed Public Benefit Corp after Aquis IPO. Robert Nygren. View the latest PanGenomic Health Inc. 778 743 4642 778 743 4642. 30 per Class A Common Share of the Company (a “Share”) to $0. VANCOUVER, BC, Dec. said that it has appointed Maryam Marissen as President & chief executive officer, effective immediately. CSE) on Friday announced the soft launch of thePanGenomic offers a self-care digital platform to deliver personalized, evidence-based information about natural and plant-based health treatments, according to the company. Die Nutzung der comdirect-Website ist ohne JavaScript nicht möglich. com info@pangenomic. PANGENOMIC HEALTH A Bilanz - hier erhalten Sie ausführliche Bilanzinformationen zur PANGENOMIC HEALTH A Aktie. PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. Pangenomic Health Inc. (RTTNews) - PanGenomic Health Inc. 01 a year ago. 0 out of 5. 07. | CA69842E2050. operates as a health care platform company. VANCOUVER, BC, Jan. PanGenomic Health Inc. Vancouver, Canada pangenomic. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. Pangenomic Health A Dividenden Chart in CAD Aktien handeln zu Top-Konditionen Aktien, ETFs, Derivate, Kryptos und mehr - jetzt für 0 Euro pro Trade handeln (zzgl. Nachrichten zur Aktie EGF Theramed Health Corp Registered Shs | A3DMEG | EVAHF. Mydecine to sell Mindleap to Pangenomic for $4M via LOI 2022-09-02 - Mr. PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. (NARA. Pangenomic Health Inc. PanGenomic Health Inc. Dear Shareholders, As we. 1 Year Return –81. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app.